The molecular cytogenetics market size has grown strongly in recent years. It will grow from $2.85 billion in 2024 to $3.12 billion in 2025 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to rise in genetic disorders and cancer cases, growing demand for personalized medicine, research and development in life sciences, clinical applications for prenatal and postnatal diagnosis, global initiatives in genomic medicine.
The molecular cytogenetics market size is expected to see rapid growth in the next few years. It will grow to $4.67 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to emergence of next-generation sequencing (NGS), increased focus on liquid biopsies, growing application in cancer research, expanding applications in infectious disease diagnosis, rapid growth in genetic testing services. Major trends in the forecast period include next-generation sequencing (NGS) in cytogenetic, automation and high-throughput screening, fluorescence in situ hybridization (fish) advancements, rising application in cancer diagnostics, single-cell analysis.
The anticipated rise in genetic disorders and cancer cases is projected to be a significant driver for the molecular cytogenetics market growth. This field focuses on examining tissue and blood samples to identify chromosome alterations indicating genetic conditions or certain cancer types. Forecasts by the American Cancer Society suggest a global surge in new cancer cases and related deaths by 2040. In 2022, the United States alone witnessed over 1.9 million new cancer cases and more than 600,000 deaths, including a daily average of approximately 350 deaths from lung cancer. These statistics underscore the market's growth fueled by the increasing incidence of genetic disorders and cancer.
The increasing adoption of personalized medicine is expected to significantly boost the growth of the molecular cytogenetics market. Personalized medicine tailors healthcare treatments to the unique characteristics of individual patients, enhancing the effectiveness of therapies. Molecular cytogenetics plays a crucial role in this approach by identifying chromosomal changes and genetic abnormalities, providing vital insights that guide personalized treatment strategies. For example, in February 2024, the Personalized Medicine Coalition, a U.S.-based non-profit organization, reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, a notable increase from six in 2022. Among these approvals were seven cancer drugs and three treatments for other diseases and conditions. This trend highlights the growing importance of molecular cytogenetics in developing targeted therapies, thereby driving market growth.
Major companies in the molecular cytogenetics market are increasingly focused on introducing advanced solutions like cytogenetic diagnostics to enhance diagnostic accuracy and improve patient outcomes. Cytogenetic diagnostics involves analyzing chromosomes and their structural characteristics to identify genetic disorders, chromosomal abnormalities, and related conditions through techniques such as karyotyping and fluorescence in situ hybridization (FISH). For instance, in July 2023, the Centre for Cellular and Molecular Biology (CCMB), an India-based research institute, launched optical genome mapping. This cutting-edge genetic testing method significantly enhances the capabilities of genetic diagnostics by allowing high-resolution analysis of genomes. This technology is crucial for identifying structural variations in DNA that may be associated with various genetic disorders, thereby providing valuable insights for personalized treatment approaches. The adoption of such innovative diagnostic solutions is expected to drive the growth of the molecular cytogenetics market further.
Companies within the molecular cytogenetics domain are actively developing innovative products, exemplified by the LUTHOR High-Definition Single Cell 3' mRNA-Seq Kit. This kit, unveiled by Lexogen in November 2023, reshapes single-cell RNA sequencing by employing an RNA-amplification-based method that detects nearly every mRNA molecule within a cell. It captures 95% of expressed genes at a depth of 1 million reads, enabling the detection of even a single gene copy in a cell. The kit's remarkable sensitivity relies on the groundbreaking THOR (T7 High-resolution Original RNA amplification) technology, surpassing limitations associated with low-copy transcripts.
In January 2022, Calibre Scientific, a US-based supplier of life science reagents, tools, instruments, and various consumables to laboratory research, diagnostics, industrial, and biopharmaceutical sectors, successfully acquired AmpliTech for an undisclosed sum. This strategic acquisition allows Calibre Scientific to incorporate another significant brand into its European distribution division. AmpliTech, headquartered in France, specializes in molecular pathology, cytogenetics, and molecular genetics, contributing valuable expertise and products in these domains.
Major companies operating in the molecular cytogenetics market include Abbott Laboratories, Agilent Technologies Inc, Applied Spectral Imaging, CytoTest Inc, Danaher Corporation, Illumina Inc, PerkinElmer Inc, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Oxford Gene Technology Limited, Affymetrix Inc, NeoGenomics Laboratories Inc, Quest Diagnostics, F. Hoffmann-La Roche AG, Bi Biological industries, Cytognomix Inc, Empire Genomics LLC., Genial Genetic Solutions Ltd., BioChain Institute Inc., BioGenex Laboratories Inc., Bio-Techne Corporation, Cytocell Ltd., Kreatech Diagnostics B.V., Leica Biosystems Nussloch GmbH, MetaSystems Group Holding GmbH, MolecularMD Corporation, Natera Inc., Opko Health Inc., PathGroup Inc., Roche Diagnostics Corporation, SciGene Corporation, SkylineDx B.V.
North America was the largest region in the molecular cytogenetics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global molecular cytogenetics market report during the forecast period. The regions covered in the molecular cytogenetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the molecular cytogenetics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Molecular cytogenetics encompasses a suite of techniques employed to study the entire genome or specific targeted DNA sequences. It involves understanding the structural and functional organization of chromosomes and nuclei, exploring genome variations, gene expression, evolution, chromosome anomalies, and genomic variations within medical genetics and tumor genetics.
The primary offerings within the molecular cytogenetics market include instruments, kits and reagents, software, services, as well as consumables or accessories. Software pertains to sets of instructions, data, or programs utilized to operate computers and perform specific tasks. The technologies employed encompass comparative genomic hybridization, fluorescence in situ hybridization, immunohistochemistry, karyotyping, and other related methodologies. Applications of these technologies extend to areas such as genetic disorders, cancer research, personalized medicine, among others. End-users encompass clinical and research laboratories, academic research institutes, pharmaceutical and biotechnology companies, and various other entities involved in these scientific pursuits.
The molecular cytogenetics market research report is one of a series of new reports that provides molecular cytogenetics market statistics, including molecular cytogenetics global market size, regional shares, competitors with an molecular cytogenetics market share, detailed molecular cytogenetics market segments, market trends and opportunities, and any further data you may need to thrive in the molecular cytogenetics industry. This molecular cytogenetics market research report deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The molecular cytogenetics market consists of revenues earned by entities by providing in situ hybridization, and banding techniques. The market value includes the value of related goods sold by the service provider or included within the service offering. The molecular cytogenetics market also includes sales of diagnostic tools, and instrumentation which are used for providing molecular cytogenetics services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The molecular cytogenetics market size is expected to see rapid growth in the next few years. It will grow to $4.67 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to emergence of next-generation sequencing (NGS), increased focus on liquid biopsies, growing application in cancer research, expanding applications in infectious disease diagnosis, rapid growth in genetic testing services. Major trends in the forecast period include next-generation sequencing (NGS) in cytogenetic, automation and high-throughput screening, fluorescence in situ hybridization (fish) advancements, rising application in cancer diagnostics, single-cell analysis.
The anticipated rise in genetic disorders and cancer cases is projected to be a significant driver for the molecular cytogenetics market growth. This field focuses on examining tissue and blood samples to identify chromosome alterations indicating genetic conditions or certain cancer types. Forecasts by the American Cancer Society suggest a global surge in new cancer cases and related deaths by 2040. In 2022, the United States alone witnessed over 1.9 million new cancer cases and more than 600,000 deaths, including a daily average of approximately 350 deaths from lung cancer. These statistics underscore the market's growth fueled by the increasing incidence of genetic disorders and cancer.
The increasing adoption of personalized medicine is expected to significantly boost the growth of the molecular cytogenetics market. Personalized medicine tailors healthcare treatments to the unique characteristics of individual patients, enhancing the effectiveness of therapies. Molecular cytogenetics plays a crucial role in this approach by identifying chromosomal changes and genetic abnormalities, providing vital insights that guide personalized treatment strategies. For example, in February 2024, the Personalized Medicine Coalition, a U.S.-based non-profit organization, reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, a notable increase from six in 2022. Among these approvals were seven cancer drugs and three treatments for other diseases and conditions. This trend highlights the growing importance of molecular cytogenetics in developing targeted therapies, thereby driving market growth.
Major companies in the molecular cytogenetics market are increasingly focused on introducing advanced solutions like cytogenetic diagnostics to enhance diagnostic accuracy and improve patient outcomes. Cytogenetic diagnostics involves analyzing chromosomes and their structural characteristics to identify genetic disorders, chromosomal abnormalities, and related conditions through techniques such as karyotyping and fluorescence in situ hybridization (FISH). For instance, in July 2023, the Centre for Cellular and Molecular Biology (CCMB), an India-based research institute, launched optical genome mapping. This cutting-edge genetic testing method significantly enhances the capabilities of genetic diagnostics by allowing high-resolution analysis of genomes. This technology is crucial for identifying structural variations in DNA that may be associated with various genetic disorders, thereby providing valuable insights for personalized treatment approaches. The adoption of such innovative diagnostic solutions is expected to drive the growth of the molecular cytogenetics market further.
Companies within the molecular cytogenetics domain are actively developing innovative products, exemplified by the LUTHOR High-Definition Single Cell 3' mRNA-Seq Kit. This kit, unveiled by Lexogen in November 2023, reshapes single-cell RNA sequencing by employing an RNA-amplification-based method that detects nearly every mRNA molecule within a cell. It captures 95% of expressed genes at a depth of 1 million reads, enabling the detection of even a single gene copy in a cell. The kit's remarkable sensitivity relies on the groundbreaking THOR (T7 High-resolution Original RNA amplification) technology, surpassing limitations associated with low-copy transcripts.
In January 2022, Calibre Scientific, a US-based supplier of life science reagents, tools, instruments, and various consumables to laboratory research, diagnostics, industrial, and biopharmaceutical sectors, successfully acquired AmpliTech for an undisclosed sum. This strategic acquisition allows Calibre Scientific to incorporate another significant brand into its European distribution division. AmpliTech, headquartered in France, specializes in molecular pathology, cytogenetics, and molecular genetics, contributing valuable expertise and products in these domains.
Major companies operating in the molecular cytogenetics market include Abbott Laboratories, Agilent Technologies Inc, Applied Spectral Imaging, CytoTest Inc, Danaher Corporation, Illumina Inc, PerkinElmer Inc, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Oxford Gene Technology Limited, Affymetrix Inc, NeoGenomics Laboratories Inc, Quest Diagnostics, F. Hoffmann-La Roche AG, Bi Biological industries, Cytognomix Inc, Empire Genomics LLC., Genial Genetic Solutions Ltd., BioChain Institute Inc., BioGenex Laboratories Inc., Bio-Techne Corporation, Cytocell Ltd., Kreatech Diagnostics B.V., Leica Biosystems Nussloch GmbH, MetaSystems Group Holding GmbH, MolecularMD Corporation, Natera Inc., Opko Health Inc., PathGroup Inc., Roche Diagnostics Corporation, SciGene Corporation, SkylineDx B.V.
North America was the largest region in the molecular cytogenetics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global molecular cytogenetics market report during the forecast period. The regions covered in the molecular cytogenetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the molecular cytogenetics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Molecular cytogenetics encompasses a suite of techniques employed to study the entire genome or specific targeted DNA sequences. It involves understanding the structural and functional organization of chromosomes and nuclei, exploring genome variations, gene expression, evolution, chromosome anomalies, and genomic variations within medical genetics and tumor genetics.
The primary offerings within the molecular cytogenetics market include instruments, kits and reagents, software, services, as well as consumables or accessories. Software pertains to sets of instructions, data, or programs utilized to operate computers and perform specific tasks. The technologies employed encompass comparative genomic hybridization, fluorescence in situ hybridization, immunohistochemistry, karyotyping, and other related methodologies. Applications of these technologies extend to areas such as genetic disorders, cancer research, personalized medicine, among others. End-users encompass clinical and research laboratories, academic research institutes, pharmaceutical and biotechnology companies, and various other entities involved in these scientific pursuits.
The molecular cytogenetics market research report is one of a series of new reports that provides molecular cytogenetics market statistics, including molecular cytogenetics global market size, regional shares, competitors with an molecular cytogenetics market share, detailed molecular cytogenetics market segments, market trends and opportunities, and any further data you may need to thrive in the molecular cytogenetics industry. This molecular cytogenetics market research report deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The molecular cytogenetics market consists of revenues earned by entities by providing in situ hybridization, and banding techniques. The market value includes the value of related goods sold by the service provider or included within the service offering. The molecular cytogenetics market also includes sales of diagnostic tools, and instrumentation which are used for providing molecular cytogenetics services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Molecular Cytogenetics Market Characteristics3. Molecular Cytogenetics Market Trends and Strategies4. Molecular Cytogenetics Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid and Recovery on the Market32. Global Molecular Cytogenetics Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Molecular Cytogenetics Market34. Recent Developments in the Molecular Cytogenetics Market
5. Global Molecular Cytogenetics Growth Analysis and Strategic Analysis Framework
6. Molecular Cytogenetics Market Segmentation
7. Molecular Cytogenetics Market Regional and Country Analysis
8. Asia-Pacific Molecular Cytogenetics Market
9. China Molecular Cytogenetics Market
10. India Molecular Cytogenetics Market
11. Japan Molecular Cytogenetics Market
12. Australia Molecular Cytogenetics Market
13. Indonesia Molecular Cytogenetics Market
14. South Korea Molecular Cytogenetics Market
15. Western Europe Molecular Cytogenetics Market
16. UK Molecular Cytogenetics Market
17. Germany Molecular Cytogenetics Market
18. France Molecular Cytogenetics Market
19. Italy Molecular Cytogenetics Market
20. Spain Molecular Cytogenetics Market
21. Eastern Europe Molecular Cytogenetics Market
22. Russia Molecular Cytogenetics Market
23. North America Molecular Cytogenetics Market
24. USA Molecular Cytogenetics Market
25. Canada Molecular Cytogenetics Market
26. South America Molecular Cytogenetics Market
27. Brazil Molecular Cytogenetics Market
28. Middle East Molecular Cytogenetics Market
29. Africa Molecular Cytogenetics Market
30. Molecular Cytogenetics Market Competitive Landscape and Company Profiles
31. Molecular Cytogenetics Market Other Major and Innovative Companies
35. Molecular Cytogenetics Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Molecular Cytogenetics Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on molecular cytogenetics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for molecular cytogenetics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The molecular cytogenetics market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Product: Instruments; Kits and Reagents; Software; Services; Consumables or Accessories2) By Technology: Comparative Genomic Hybridization; Fluorescence in Situ Hybridization; Immunohistochemistry; Karyotyping; Other Technologies
3) By Application: Genetic Disorders; Cancer; Personalized Medicines; Other Applications
4) By End-User: Clinical and Research Laboratories; Academic Research Institutes; Pharmaceutical; Biotechnology Companies; Other End-Users
Subsegments:
1) By Instruments: Fluorescence in Situ Hybridization (FISH) Systems; Microarray Platforms; Next-Generation Sequencing (NGS) Instruments; Chromatography Systems; Imaging Systems2) By Kits and Reagents: DNA Extraction Kits; RNA Isolation Kits; PCR Kits; Hybridization Kits; Staining Kits
3) By Software: Data Analysis Software; Image Analysis Software; Bioinformatics Tools; Laboratory Information Management Systems (LIMS); Reporting Software
4) By Services: Custom Research Services; Technical Support Services; Consulting Services; Training Services; Quality Control Services
5) By Consumables or Accessories: Pipettes and Tips; Reagent Plates; Glass Slides and Coverslips; Sample Storage Containers; Assay Plates
Key Companies Mentioned: Abbott Laboratories; Agilent Technologies Inc; Applied Spectral Imaging; CytoTest Inc; Danaher Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
Some of the major companies featured in this Molecular Cytogenetics market report include:- Abbott Laboratories
- Agilent Technologies Inc
- Applied Spectral Imaging
- CytoTest Inc
- Danaher Corporation
- Illumina Inc
- PerkinElmer Inc
- Thermo Fisher Scientific Inc
- Bio-Rad Laboratories Inc
- Oxford Gene Technology Limited
- Affymetrix Inc
- NeoGenomics Laboratories Inc
- Quest Diagnostics
- F. Hoffmann-La Roche AG
- Bi Biological industries
- Cytognomix Inc
- Empire Genomics LLC.
- Genial Genetic Solutions Ltd.
- BioChain Institute Inc.
- BioGenex Laboratories Inc.
- Bio-Techne Corporation
- Cytocell Ltd.
- Kreatech Diagnostics B.V.
- Leica Biosystems Nussloch GmbH
- MetaSystems Group Holding GmbH
- MolecularMD Corporation
- Natera Inc.
- Opko Health Inc.
- PathGroup Inc.
- Roche Diagnostics Corporation
- SciGene Corporation
- SkylineDx B.V.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | February 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 3.12 Billion |
| Forecasted Market Value ( USD | $ 4.67 Billion |
| Compound Annual Growth Rate | 10.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 33 |
